| RCC | renal cell carcinoma |
| VHL | Von-Hippel Lindau tumor suppressor |
| VEGF | vascular endothelial growth factor |
| PDGF | platelet-derived growth factor |
| ATG | autophagy-related gene |
| PFS | progression-free survival |
| PR | partial response |
| DLT | dose-limiting toxicity |
| SD | stable disease |
| CR | complete response |
| HDAC | histone deacetylase |
| AE | adverse event |
| HCQ | hydroxychloroquine |
| CQ | chloroquine |
| IHC | immunohistochemistry |
| ULK | UNC-51 like kinase |
| CTLA-4 | cytotoxic t-lymphocyte associated protein 4 |
| PD-L1 | Programmed cell death ligand 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.